Oral vs. Subcutaneous Semaglutide in Type 2 Diabetes Mellitus
NCT07056803
·
clinicaltrials.gov ↗
COMPLETED
Status
212
Enrollment
OTHER
Sponsor class
Conditions
Diabetes Mellitus Type 2
Interventions
DRUG:
Oral semaglutide
DRUG:
subcutaneous semaglutide
Sponsor
University of Palermo